0001070081-19-000034.txt : 20190603
0001070081-19-000034.hdr.sgml : 20190603
20190603173944
ACCESSION NUMBER: 0001070081-19-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190531
FILED AS OF DATE: 20190603
DATE AS OF CHANGE: 20190603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hill Emily Luisa
CENTRAL INDEX KEY: 0001778279
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 19874499
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
wf-form4_155959796974204.xml
FORM 4
X0306
4
2019-05-31
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001778279
Hill Emily Luisa
C/O PTC THERAPEUTICS INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Chief Financial Officer
Common Stock
7605
D
Stock Option (Right To Buy)
40.1
2019-05-31
4
A
0
50000
40.10
A
2029-05-30
Common Stock
50000.0
50000
D
Stock Option (Right To Buy)
43.69
2024-09-24
Common Stock
7000.0
7000
D
Stock Option (Right To Buy)
51.0
2025-01-02
Common Stock
1620.0
1620
D
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
2430.0
2430
D
Stock Option (Right To Buy)
11.23
2027-01-02
Common Stock
3825.0
3825
D
Stock Option (Right To Buy)
18.01
2028-01-03
Common Stock
14000.0
14000
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
21210.0
21210
D
This option was granted on May 31, 2019 and vests over four years, with 25% of the shares underlying the option vesting on May 31, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning August 31, 2020.
Currently exercisable.
This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
Avraham S. Adler, attorney-in-fact
2019-06-03